Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anti-BCL2L13 antibody (STJ191960) | Login | Anti-BCL2L13 antibody (STJ191960) | ||||||||||||||||
|
||||||||||||||||||
Anti-STK17A antibody (STJ191970) | Login | Anti-STK17A antibody (STJ191970) | ||||||||||||||||
|
||||||||||||||||||
Anti-DOT1L antibody (700-780 aa) (STJ191842) | Login | Anti-DOT1L antibody (700-780 aa) (STJ191842) | ||||||||||||||||
|
||||||||||||||||||
Anti-FGFBP1 antibody (110-190 aa) (STJ191847) | Login | Anti-FGFBP1 antibody (110-190 aa) (STJ191847) | ||||||||||||||||
|
||||||||||||||||||
Anti-CDK16 antibody (STJ191978) | Login | Anti-CDK16 antibody (STJ191978) | ||||||||||||||||
|
||||||||||||||||||
Anti-PRKCI antibody (STJ191982) | Login | Anti-PRKCI antibody (STJ191982) | ||||||||||||||||
|
||||||||||||||||||
Anti-PRKG1 antibody (STJ191983) | Login | Anti-PRKG1 antibody (STJ191983) | ||||||||||||||||
|
||||||||||||||||||
Anti-HSPA4L antibody (450-530 aa) (STJ191854) | Login | Anti-HSPA4L antibody (450-530 aa) (STJ191854) | ||||||||||||||||
|
||||||||||||||||||
Anti-SRMS antibody (STJ191989) | Login | Anti-SRMS antibody (STJ191989) | ||||||||||||||||
|
||||||||||||||||||
Anti-TRIB3 antibody (STJ191991) | Login | Anti-TRIB3 antibody (STJ191991) | ||||||||||||||||
|
||||||||||||||||||
Anti-TSSK1B antibody (STJ191993) | Login | Anti-TSSK1B antibody (STJ191993) | ||||||||||||||||
|
||||||||||||||||||
Anti-KDM5B antibody (STJ191877) | Login | Anti-KDM5B antibody (STJ191877) | ||||||||||||||||
|
||||||||||||||||||
Anti-JAML antibody (STJ191879) | Login | Anti-JAML antibody (STJ191879) | ||||||||||||||||
|
||||||||||||||||||
Anti-SFRP4 antibody (STJ192099) | Login | Anti-SFRP4 antibody (STJ192099) | ||||||||||||||||
|
||||||||||||||||||
Anti-OLIG3 antibody (STJ192100) | Login | Anti-OLIG3 antibody (STJ192100) | ||||||||||||||||
|
||||||||||||||||||
Anti-SFRP1 antibody (STJ192103) | Login | Anti-SFRP1 antibody (STJ192103) | ||||||||||||||||
|
||||||||||||||||||
Anti-FCRL4 antibody (STJ192104) | Login | Anti-FCRL4 antibody (STJ192104) | ||||||||||||||||
|
||||||||||||||||||
Anti-PRNP antibody (STJ192113) | Login | Anti-PRNP antibody (STJ192113) | ||||||||||||||||
|
||||||||||||||||||
Anti-PARP6 antibody (STJ192118) | Login | Anti-PARP6 antibody (STJ192118) | ||||||||||||||||
|
||||||||||||||||||
Anti-OTOR antibody (STJ192121) | Login | Anti-OTOR antibody (STJ192121) | ||||||||||||||||
|
||||||||||||||||||
Anti-NRARP antibody (1-50 aa) (STJ192122) | Login | Anti-NRARP antibody (1-50 aa) (STJ192122) | ||||||||||||||||
|
||||||||||||||||||
Anti-TXNDC5 antibody (STJ192123) | Login | Anti-TXNDC5 antibody (STJ192123) | ||||||||||||||||
|
||||||||||||||||||
Anti-CLUL1 antibody (STJ192124) | Login | Anti-CLUL1 antibody (STJ192124) | ||||||||||||||||
|
||||||||||||||||||
Anti-C1QTNF1 antibody (STJ192127) | Login | Anti-C1QTNF1 antibody (STJ192127) | ||||||||||||||||
|
||||||||||||||||||
Anti-FCN2 antibody (41-90 aa) (STJ192128) | Login | Anti-FCN2 antibody (41-90 aa) (STJ192128) | ||||||||||||||||
|